Xie L, Li Z
The State Key Laboratory Breeding Base of Basic Science of Stomatology & Key Laboratory of Oral Biomedicine Ministry of Education, School of Stomatology, Wuhan University, Wuhan 430079, China.
Zhonghua Kou Qiang Yi Xue Za Zhi. 2021 Jun 9;56(6):565-569. doi: 10.3760/cma.j.cn112144-20201020-00532.
To evaluate the effect of preventive use of etocoxib-induced preemptive analgesia on three types of pain (wound pain, swallowing pain, mouth opening pain) after extraction of impacted teeth. In this study, 60 patients (60 teeth) with impacted mandibular third molars in Department of Jinyintan Outpatient, School of Stomatology, Wuhan University from May to October 2020 were enrolled. The patients were numbered by SPSS 21.0 and randomly divided into two groups. The odd number was included in the etocoxib group, and the even number was included in the control group, with 30 cases in each group. Patients in the two groups were given etocoxib 60 mg or placebo vitamin C 100 mg 30 min before operation. Pain at 2, 4, 6, 8, 10, 12, and 24 hours after tooth extraction was recorded with numeric rating scale (NRS) score. The total dose of ibuprofen rescue intake was recorded. Kaplan-Meier curves and Log-Rank analyses were used to evaluate the proportion of patients without rescue analgesic. The NRS scores of wound pain, swallowing pain and mouth opening pain in the etoricoxib group were lower than those in the control group within 24 hours after tooth extraction (<0.05). The total dose of emergency analgesics in the etoricoxib group [(0.7±0.7) dose] was lower than that in the control group [(1.4±0.9) dose] (<0.01). The mean time between first application of analgesics was 11.5 hours in etoricoxib group and 3.5 hours in the placebo group, respectively (<0.05). This study revealed that etoricoxib has a substantial preemptive analgesic effect, resulting in the reduced use of analgesics after third molar removal.
评估预防性使用依托考昔诱导的超前镇痛对阻生齿拔除后三种疼痛(伤口疼痛、吞咽疼痛、张口疼痛)的影响。本研究纳入了2020年5月至10月武汉大学口腔医学院金银潭门诊部60例(60颗牙)下颌阻生第三磨牙患者。采用SPSS 21.0对患者进行编号并随机分为两组。奇数号纳入依托考昔组,偶数号纳入对照组,每组30例。两组患者在手术前30分钟分别给予依托考昔60mg或安慰剂维生素C 100mg。采用数字评分量表(NRS)评分记录拔牙后2、4、6、8、10、12和24小时的疼痛情况。记录布洛芬解救用药的总剂量。采用Kaplan-Meier曲线和Log-Rank分析评估未使用解救镇痛药的患者比例。拔牙后24小时内,依托考昔组伤口疼痛、吞咽疼痛和张口疼痛的NRS评分低于对照组(<0.05)。依托考昔组的急救镇痛药总剂量[(0.7±0.7)剂]低于对照组[(1.4±0.9)剂](<0.01)。依托考昔组首次使用镇痛药的平均时间为11.5小时,安慰剂组为3.5小时(<0.05)。本研究表明,依托考昔具有显著的超前镇痛作用,可减少第三磨牙拔除后镇痛药的使用。